28.07.2015
- With the opening of a new facility in Glasgow, Scotland, toll manufacturer BioOutsource, part of Sartorius Stedim Biotech group, said it has doubled its capacity to support its...
24.07.2015
- A US federal appeals court has ruled that Swiss drugmaker Novartis can begin selling Zarxio, its lower-cost generic version of an Amgen drug, on the US market starting in September...
20.04.2015
- French biopharmaceutical industry contract supplier Sartorius Stedim Biotech (SSM) has acquired BioSource, a privately owned Glasgow, Scotland-based biotech firm for an undisclosed...
16.03.2015
- The US Food & Drug Administration has approved the country's first biosimilar product, a move observers say will open the door for lower cost, generic-like biological drugs. The...
21.01.2015
- CPhI Worldwide has announced the launch of a new advisory board, consisting of the following industry experts who provide a wide expertise portfolio: Alan Sheppard, Principal...
30.09.2014
- Dramatic changes to the scientific and business environments have made it impossible for pharmaceutical companies to continue operating as they have in the past. A perceived...
08.06.2014
- The pharmerging markets will still be extending their progress by 10 to 13%, as population increases and rising incomes contribute to dramatically higher use of medicines. Improved...
06.06.2014
- Giving Pharma a Boost - Brazil's business environment is notoriously cumbersome. The manufacturing sector in particular suffers from high tax rates, poor infrastructure and...
